USANA HEALTH SCIENCES INC - COMMON STOCK, $0.001 par value per share (USNA)
CUSIP: 90328M107
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / COMMON STOCK, $0.001 par value per share
- Shares outstanding
- 18,474,676
- Total 13F shares
- 3,827,662
- Share change
- -268,592
- Total reported value
- $66,868,220
- Price per share
- $17.47
- Number of holders
- 57
- Value change
- -$4,860,241
- Number of buys
- 19
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 90328M107?
CUSIP 90328M107 identifies USNA - USANA HEALTH SCIENCES INC - COMMON STOCK, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 90328M107:
Top shareholders of USNA - USANA HEALTH SCIENCES INC - COMMON STOCK, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Myron W. Wentz |
3/4/5
13D/G
|
10%+ Owner · Gull Global Limited |
40%
from 13D/G
|
7,408,345
|
$217,731,259 | — | 03 Sep 2025 | |
| PZENA INVESTMENT MANAGEMENT LLC |
13D/G
13F
|
Company |
6.6%
|
1,212,588
|
$33,406,921 | +$4,490,060 | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
6.2%
|
1,147,323
|
$22,521,950 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
1,112,001
|
$21,828,580 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.1%
|
934,316
|
$18,340,623 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
13D/G
|
Company |
4.6%
from 13D/G
|
848,452
|
$16,655,396 | — | 31 Dec 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
3.2%
|
585,074
|
$11,485,003 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.9%
|
353,946
|
$6,947,960 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.6%
|
300,591
|
$5,900,602 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.5%
|
285,416
|
$5,602,716 | — | 31 Dec 2025 | |
| Jim Brown |
3/4/5
|
CEO & PRESIDENT |
—
mixed-class rows
|
177,812
mixed-class rows
|
$5,125,623 | — | 24 Jul 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
254,820
|
$5,003,300 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.4%
|
252,095
|
$4,948,625 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
239,177
|
$4,695,045 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.1%
|
209,984
|
$4,121,986 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
202,586
|
$3,976,763 | — | 31 Dec 2025 | |
| Kevin Guest |
3/4/5
|
CEO & EXEC. CHAIRMAN OF BOARD |
—
mixed-class rows
|
172,587
mixed-class rows
|
$3,095,985 | — | 27 Feb 2026 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.82%
|
151,416
|
$2,972,297 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.75%
|
138,334
|
$2,715,496 | — | 31 Dec 2025 | |
| Creative Planning |
13F
|
Company |
0.67%
|
124,509
|
$2,444,112 | — | 31 Dec 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.59%
|
109,686
|
$2,153,136 | — | 31 Dec 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.55%
|
102,466
|
$2,011,408 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.54%
|
100,588
|
$1,974,542 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
97,845
|
$1,920,697 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.52%
|
96,422
|
$1,892,764 | — | 31 Dec 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
93,237
|
$1,830,242 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
92,283
|
$1,811,515 | — | 31 Dec 2025 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.48%
|
88,826
|
$1,743,654 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.46%
|
84,282
|
$1,654,456 | — | 31 Dec 2025 | |
| Walter Noot |
3/4/5
|
CHIEF OPERATING OFFICER |
—
mixed-class rows
|
84,386
mixed-class rows
|
$1,613,097 | -$190,568 | 27 Feb 2026 | |
| G. Doug Iiekking |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
81,109
mixed-class rows
|
$1,560,418 | — | 27 Feb 2026 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.41%
|
74,924
|
$1,470,758 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.4%
|
73,889
|
$1,450,440 | — | 31 Dec 2025 | |
| Brent Neidig |
3/4/5
|
CHIEF COMMERCIAL OFFICER |
—
mixed-class rows
|
74,960
mixed-class rows
|
$1,395,100 | — | 27 Feb 2026 | |
| Walleye Capital LLC |
13F
|
Company |
0.36%
|
66,269
|
$1,300,860 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.36%
|
65,700
|
$1,289,691 | — | 31 Dec 2025 | |
| Daniel A. Macuga |
3/4/5
|
CHIEF COMMUNICATIONS OFFICER |
—
class O/S missing
|
23,920
|
$1,216,332 | — | 02 May 2024 | |
| Empowered Funds, LLC |
13F
|
Company |
0.33%
|
60,437
|
$1,186,378 | — | 31 Dec 2025 | |
| Paul A. Jones |
3/4/5
|
CHIEF PEOPLE OFFICER |
—
mixed-class rows
|
58,985
mixed-class rows
|
$1,155,513 | — | 27 Feb 2026 | |
| Robert A. Sinnott |
3/4/5
|
CHIEF SCIENTIFIC OFFICER |
—
class O/S missing
|
22,033
|
$1,120,378 | — | 05 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
56,202
|
$1,103,245 | — | 31 Dec 2025 | |
| David Mulham Mulham |
3/4/5
|
CHIEF SALES OFFICER |
—
mixed-class rows
|
41,058
mixed-class rows
|
$1,094,182 | -$124,697 | 10 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
54,580
|
$1,071,399 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.28%
|
52,555
|
$1,031,655 | — | 31 Dec 2025 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.28%
|
52,411
|
$1,028,828 | — | 31 Dec 2025 | |
| Numerai GP LLC |
13F
|
Company |
0.28%
|
52,328
|
$1,027,199 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.27%
|
49,271
|
$967,191 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.25%
|
46,247
|
$907,829 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.2%
|
37,823
|
$742,466 | — | 31 Dec 2025 | |
| Peter Benedict |
3/4/5
|
CHIEF INFORMATION OFFICER |
—
class O/S missing
|
38,602
|
$677,744 | -$144,260 | 03 Mar 2026 |
Institutional Holders of USANA HEALTH SCIENCES INC - COMMON STOCK, $0.001 par value per share (USNA) as of Q1 2026
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.